I fully agree. IPIX has the goods and they know it. They
I fully agree. IPIX has the goods and they know it. They will do a deal when it is right. I very much appreciate the fact that Leo keeps us shareholders informed regularly. Yes it does give the bashers and crooks the same information that they can skew and create false narratives with. However; I would much rather know the actual status of things straight from the company even if it means we have to deal with the noise from the attackers.
FWIW, I forwarded the year end letter to a friend of mine who I discussed CTIX with years ago. He did a surface investigation and was scared away by the old false narratives against Leo and Menon and the other crap that the bashers have always spewed. He told me I should get all my money out asap and run from CTIX. It put a little fear in me until I realized that his tolerance for risk and general lack of understanding in early stage biotech was the true driver for him being easily swayed by the incorrect narratives. Fortunately for him I dont hold a grudge, and VERY fortunately for him he still has a chance to get in a lower prices than me for a SIGNIFICANTLY de-risked investment compared to ~4 years ago. I will let the board know if he comes to his senses and decides to start a position in the coming weeks.
(Also to be noted; in the last 4 years he has made a lot of money in other ventures, so I am willing to bet his risk tolerance is a lot greater since he has a fair amount of cash to gamble.)
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Top 5 Most Recently Viewed Articles
Politan Capital Pushes for Change in Masimo's Boardroom Politan Capital Management, a major stakeholder in Masimo Corporation (NASDAQ: MASI) with a shareholding of 8.9%, is calling on fellow shareholders to back its efforts to reform the board of Masimo. As the Annual Meeting approaches, the company seeks to introduce new perspectives by electing independent directors who...
Continue Reading
Overview of the Tender Offer by Paratus Energy Services Ltd. Paratus Energy Services Ltd. has announced a significant cash tender offer aimed at purchasing up to $17,607,991 in Senior Secured Notes, which are due in 2026. This strategic move follows the company's previous successful share sales, showcasing its commitment to enhancing its financial position and shareholder...
Continue Reading
Sigma Foods Reports Impressive EBITDA Figures for 2025 Sigma Foods has announced remarkable financial results for the fourth quarter and full year of 2025, showcasing a robust EBITDA of US $278 million in 4Q25, contributing to a total of US $1.1 billion in the entire year. These impressive metrics reflect the company's successful strategies and dedication to driving...
Continue Reading
Verkkokauppa.com Completes Organizational Restructuring Verkkokauppa.com Oyj has recently completed significant change negotiations aimed at renewing and streamlining its organizational structure. This initiative is designed to foster profitable growth and enhance operational efficiency across various departments. Goals for Organizational Change The restructuring plan,...
Continue Reading
Highlights from W5's Investigation into Quantum BioPharma Quantum BioPharma Ltd. (NASDAQ: QNTM) is currently at the center of a significant investigation featured in the acclaimed Canadian television program, W5. The program's second segment delves into the serious allegations of stock market manipulation against two major Canadian banks. This revelation has arisen from...
Continue Reading